Home/Filings/SCHEDULE 13G/A/0001072613-25-000168
SCHEDULE 13G/A//SEC Filing

Lyell Immunopharma, Inc. SCHEDULE 13G/A

Accession 0001072613-25-000168

CIK 0001666306other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 4:55 PM ET

Size

35.4 KB

Accession

0001072613-25-000168

Issuer

ARCH Venture Fund IX, L.P.

CIK 0001666306

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001666306

Filing Metadata

Form type
SCHEDULE 13G/A
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:55 PM ET
Size
35.4 KB